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SUMMARY. Targeted delivery systems for treatment of Inflammatory bowel disease (IBD) are designed to
increase local tissue concentrations of anti-inflammatory drugs from lower doses compared with systemic
administration The objective of this study was to formulate and evaluate an oral system designed to
achieve site specific and instant drug release in colon for effective treatment of IBD based on time depen-
dent approach. The system consists of core tablet containing model drug diclofenac sodium, superdisinte-
grant sodium starch glycolate, and coated with pH independent polymer Eudragit RSPO to achieve differ-
ent total percentage weight gain. Drug release studies were carried out using changing pH method. Place-
bo formulation containing barium sulphate in the tablet was administered to human volunteers for in vivo
X-ray studies. In vitro studies revealed that tablet with 5 % coating level release the drug after 5 h lag time
corresponding to the colonic region. Tablets with 5 % coating level could maintain their integrity in hu-
man volunteers for 5 h, approximating colon arrival time and release the drug instantaneously. Colon tar-
geting and instant drug release for 5 % coating level was due to swellable hydrophilic polymer, which is
responsible for a lag phase preceding the onset of release and the immediate release effect of superdisinte-
grant, It was observed that as coating level increases, lag time also increases. This is because of increased
diffusion path length and tortuosity at higher coating levels. In vivo - in vitro study reveals thickness of
coating of Eudragit RSPO play an important role in colon delivery and tablet with superdisintegrant and
5 % coating level achieved the desired performance of the colon targeting.
